Brainstorm Cell Therapeutics (BCLI)
NASDAQ:BCLI
Holding BCLI?
Track your performance easily

Brainstorm Cell Therapeutics (BCLI) Financial Statements

519 Followers

Brainstorm Cell Therapeutics Financial Overview

Brainstorm Cell Therapeutics's market cap is currently ―. The company's EPS TTM is $-0.226; its P/E ratio is -1.05; Brainstorm Cell Therapeutics is scheduled to report earnings on November 11, 2024, and the estimated EPS forecast is $-0.04. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Jun 23Mar 23Dec 22
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -2.54M$ -2.47M$ -5.45M$ -5.15M$ -4.92M
EBITDA$ -2.48M$ -2.41M$ -5.38M$ -5.08M$ -4.84M
Net Income Common Stockholders$ -2.54M$ -3.40M$ -5.57M$ -5.06M$ -5.02M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 3.47M$ 779.00K$ 748.00K$ 2.23M$ 2.98M
Total Assets$ 5.68M$ 3.35M$ 5.75M$ 7.87M$ 8.45M
Total Debt$ 962.00K$ 1.12M$ 3.29M$ 3.68M$ 4.09M
Net Debt$ -2.51M$ 342.00K$ 2.54M$ 1.45M$ 1.11M
Total Liabilities$ 9.21M$ 8.90M$ 9.63M$ 12.71M$ 11.47M
Stockholders Equity$ -3.53M$ -5.55M$ -3.44M$ -4.84M$ -3.02M
Cash Flow-
Free Cash Flow$ -1.68M$ -3.06M$ -6.78M$ -3.99M$ -4.65M
Operating Cash Flow$ -1.68M$ -3.06M$ -6.78M$ -3.99M$ -4.65M
Investing Cash Flow--$ 4.00K$ 2.00M$ 1.04M
Financing Cash Flow$ 4.37M$ 2.54M$ 5.30M$ 3.23M$ 238.00K
Currency in USD

Brainstorm Cell Therapeutics Earnings and Revenue History

Brainstorm Cell Therapeutics Debt to Assets

Brainstorm Cell Therapeutics Cash Flow

Brainstorm Cell Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis